{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044278","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.397579+00:00","generated_at":"2026-05-30T02:45:44.642149+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NAYA Biosciences regains Nasdaq equity compliance; faces one-year monitor","bullets":["Received Nasdaq notice dated Oct 30, 2024 confirming compliance with Listing Rule 5550(b)(1) (Equity Rule).","Compliance follows June 18, 2024 Panel decision; company under mandatory panel monitor for one year.","No financial results or operational updates disclosed in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044278","json":"https://secwatch.observer/filing/0001493152-24-044278.json","markdown":"https://secwatch.observer/filing/0001493152-24-044278.md","text":"https://secwatch.observer/filing/0001493152-24-044278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224044278/0001493152-24-044278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224044278/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:45:44.642149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}